江苏省冠状动脉旁路移植术注册研究:16中心7475例报告
Objective: To evaluate coronary artery bypass grafting (CABG) in Jiangsu Provinc registry database from 2019 to 2024. Methods: This is a multicenter retrospective registry study.…
要点
- ONCABG占69.75%,OPCAB占30.25%,两组术前风险因素分布存在显著差异。
- 总体院内死亡2.25%,脑卒中0.98%,心肌梗死0.48%,纵隔感染1.79%。
- ONCABG组术后急性肾损伤、透析、二次开胸、脑卒中及院内死亡均高于OPCAB组。
核心结论
- 江苏省CABG注册数据库2019至2024年总体运行良好,围术期并发症接近或优于国际先进水平。
- ONCABG组患者术前病情偏重,术后并发症发生率及院内病死率高于OPCAB组。
研究设计与样本
- 采用独立样本t检验和χ²检验比较ONCABG与OPCAB两组临床资料差异。
主要发现
- 院内死亡168例(2.25%),再次手术110例(1.47%),其中二次开胸止血86例、再次血运重建24例。
- 围术期并发症:心肌梗死36例(0.48%)、脑卒中73例(0.98%)、急性肾损伤274例(3.67%)、需透析肾衰竭100例(1.34%)、纵隔感染134例(1.79%)。
关键数值与推荐
- 与OPCAB组相比,ONCABG组术前吸烟史、高脂血症、慢性肺疾病、颈动脉狭窄、NYHA Ⅲ~Ⅳ级、PCI史比例更高,EuroSCORE Ⅱ评分更高,左主干合并三支病变更多,LVEF更低。
- ONCABG组术中输注红悬液比例更高,术后急性肾损伤、新发需透析肾衰竭、二次开胸、脑卒中、切口愈合不良发生率及院内病死率均增高(P值均<0.05)。
临床怎么用
- 应重视ONCABG患者术前风险评估与围术期管理,针对其较高的术后并发症和死亡风险加强监测与干预。
- 注册数据库可用于持续监测CABG质量并比较不同术式结局,为临床决策提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate coronary artery bypass grafting (CABG) in Jiangsu Provinc registry database from 2019 to 2024. Methods: This is a multicenter retrospective registry study. Data of the CABG registry database in Jiangsu Province from January 2019 to December 2024 were retrospectively collected. A total of 7 475 patients who underwent isolated CABG from 16 medical centers. There were 5 484 males and 1 991 females, with an age of (66.7±9.2) years (range: 23 to 92 years) and a body mass index of (24.6±3.2) kg/m2 (range:15.5 to 39.6 kg/m2).Preoperative risk factors, medical history, cardiac function were analyzed (New York Heart Association classification), coronary artery disease, European Heart Surgery Risk Assessment System Ⅱ(EuroSCORE Ⅱ) score, whether CPB was used, whether arterial bridge was used, the number and flow of bridge vessels, postoperative stroke, myocardial infarction and mediastinal infection were analyzed. Independent sample t-test and χ² test were used to compare the differences in clinical data between patients undergoing on-pump coronary artery bypass grafting (ONCABG) and off-pump coronary artery bypass grafting (OPCAB). Results: Left main coronary artery disease was present in 2 181 cases (29.18%), three-vessel disease in 6 212 cases (83.10%), and left main coronary artery disease combined with three-vessel disease in 1 987 cases (26.58%). Left ventricular ejection fraction (LVEF)<50% was observed in 1 544 cases (20.66%), cardiac function class Ⅲ to Ⅳ in 2 654 cases (35.51%), and the EuroSCORE Ⅱ score was (M(IQR)) 1.28% (1.87%) (range: 0.8% to 39.4%). There were a total of 5 214 cases of ONCABG (69.75%) and 2 261 cases of OPCAB (30.25%). The left internal mammary artery (LIMA) was used in 6 407 cases (85.71%), with skeletonized LIMA in 2 949 cases (46.03%) and pedicled LIMA in 3 458 cases (53.97%). Sixteen centers used the radial artery as conduit material. The number of grafts per patient was 3.1±1.1 (range:1 to 7). The intraoperative cardiopulmonary bypass time was (106.0±34.9) min (range:22 to 310 min), and the aortic cross-clamp time was (76.9±26.2) min (range:20 to 205 min). There were 168 in-hospital deaths (2.25%). Reoperations in 110 cases (1.47%), including 86 cases of re-sternotomy for hemostasis and 24 cases of repeat revascularization. Perioperative complications: myocardial infarction 36 cases (0.48%), stroke 73 cases (0.98%), 274 cases of acute kidney injury after operation (3.67%), 100 cases (1.34%) of renal failure requiring dialysis 134 cases (1.79%) of mediastinal infection 6 450 cases were discharged for secondary prevention compared with OPCAB group, ONCABG group had a higher proportion of patients with smoking history, higher proportion of patients with hyperlipidemia, chronic lung disease, carotid artery stenosis, cardiac function Ⅲ to Ⅳ, history of Percutaneous Coronary Intervention higher EuroSCORE Ⅱ score, more left main trunk with three vessels disease, lower LVEF, higher proportion of intraoperative red suspension infusion; Postoperative acute kidney injury, new renal failure dialysis, secondary thoracotomy, stroke, poor incision healing, and in-hospital mortality were all increased (all P<0.05). Conclusions: CABG registry database in Jiangsu Province generally operated well from 2019 to 2024. Compared with OPCAB group, ONCABG group patients had more severe preoperative conditions, higher postoperative complications and in-hospital mortality. Overall perioperative complications in Jiangsu Province were controlled close to or better than international advanced levels. 目的: 分析江苏省冠状动脉旁路移植术(CABG)注册登记数据库2019—2024年的患者数据。 方法: 本研究为多中心回顾性注册登记研究。收集2019年1月至2024年12月江苏省CABG 注册登记数据库的患者资料,该期间共收录接受单纯CABG患者7 475例,来自16个医疗中心。男性5 484例,女性1 991例,年龄(66.7±9.2)岁(范围:23~92岁),体重指数(24.6±3.2)kg/m2(范围:15.5~39.6 kg/m2)。对术前危险因素、病史、纽约心脏病协会(NYHA)心功能分级、冠状动脉病变情况、欧洲心脏手术风险评估系统Ⅱ(EuroSCORE Ⅱ)评分,是否使用体外循环、是否使用动脉桥、桥血管数量及流量,术后脑卒中、心肌梗死、纵隔感染发生情况等进行分析。采用独立样本t检验、χ²检验比较体外循环下CABG(ONCABG)和非体外循环下CABG(OPCAB)患者临床资料的差异。 结果: 7 475例患者中,左主干病变2 181例(29.18%),三支病变6 212例(83.10%),左主干合并三支病变1 987例(26.58%);左心室射血分数(LVEF)<50%者1 544例(20.66%),NYHA分级Ⅲ~Ⅳ级2 654例(35.51%),EuroSCOREⅡ评分为[M(IQR)]1.28%(1.87%)(范围:0.8%~39.4%)。行ONCABG共5 214例(69.75%),OPCAB共2 261例(30.25%)。使用左乳内动脉(LIMA)6 407例(85.71%),其中使用骨骼化LIMA 2 949例(46.03%),带蒂LIMA 3 458例(53.97%)。16家中心记录使用桡动脉作为桥血管材料病例。患者移植的桥血管数量为(3.1±1.1)支(范围:1~7支)。术中体外循环时间为(106.0±34.9)min(范围:22~310 min),主动脉阻断时间为(76.9±26.2)min(范围:20~205 min)。患者院内死亡168例(2.25%);再次手术110例(1.47%),再次手术中二次开胸止血86例,再次血运重建24例。围手术期并发症:心肌梗死36例(0.48%),脑卒中73例(0.98%),术后新发急性肾损伤274例(3.67%),新发需要透析的肾功能衰竭100例(1.34%),纵隔感染134例(1.79%)。出院后进行药物二级预防6 450例(86.29%)。与OPCAB组相比,ONCABG组有术前吸烟史的患者比例更高,合并高脂血症、慢性肺疾病、颈动脉狭窄、NYHA心功能分级Ⅲ~Ⅳ级、经皮冠状动脉介入治疗史的患者比例高、EuroSCORE Ⅱ评分高,左主干合并三支病变数多,LVEF较低;术中输注红悬液比例高,术后发生急性肾损伤、新发需要透析的肾功能衰竭、二次开胸、脑卒中、切口愈合不良的发生率及院内病死率均增高(P值均<0.05)。 结论: 江苏省CABG注册登记数据库2019至2024年总体运行良好。与OPCAB组相比,ONCABG组患者术前总体病情偏重,术后并发症发生率及院内病死率较高。.
引用
- Zang C, Ding H, Jiang HW, et al. [Jiangsu province coronary artery bypass grafting registry study: a report of 7 475 patients from 16 centers]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 42203659. doi:10.3760/cma.j.cn112139-20260209-00064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。